QQQ   354.65 (+0.75%)
AAPL   180.95 (+0.48%)
MSFT   335.40 (+0.85%)
META   272.61 (+0.00%)
GOOGL   124.67 (+0.77%)
AMZN   124.25 (+1.21%)
TSLA   213.97 (+3.11%)
NVDA   393.27 (-1.11%)
NIO   7.56 (+0.27%)
BABA   84.26 (+1.52%)
AMD   117.86 (-1.35%)
T   15.21 (-3.86%)
F   12.38 (+2.23%)
MU   69.17 (+0.12%)
CGC   0.83 (-1.20%)
GE   105.79 (+1.07%)
DIS   90.77 (+2.46%)
AMC   4.56 (+0.00%)
PFE   38.35 (+0.87%)
PYPL   63.96 (+1.44%)
NFLX   400.47 (-0.66%)
QQQ   354.65 (+0.75%)
AAPL   180.95 (+0.48%)
MSFT   335.40 (+0.85%)
META   272.61 (+0.00%)
GOOGL   124.67 (+0.77%)
AMZN   124.25 (+1.21%)
TSLA   213.97 (+3.11%)
NVDA   393.27 (-1.11%)
NIO   7.56 (+0.27%)
BABA   84.26 (+1.52%)
AMD   117.86 (-1.35%)
T   15.21 (-3.86%)
F   12.38 (+2.23%)
MU   69.17 (+0.12%)
CGC   0.83 (-1.20%)
GE   105.79 (+1.07%)
DIS   90.77 (+2.46%)
AMC   4.56 (+0.00%)
PFE   38.35 (+0.87%)
PYPL   63.96 (+1.44%)
NFLX   400.47 (-0.66%)
QQQ   354.65 (+0.75%)
AAPL   180.95 (+0.48%)
MSFT   335.40 (+0.85%)
META   272.61 (+0.00%)
GOOGL   124.67 (+0.77%)
AMZN   124.25 (+1.21%)
TSLA   213.97 (+3.11%)
NVDA   393.27 (-1.11%)
NIO   7.56 (+0.27%)
BABA   84.26 (+1.52%)
AMD   117.86 (-1.35%)
T   15.21 (-3.86%)
F   12.38 (+2.23%)
MU   69.17 (+0.12%)
CGC   0.83 (-1.20%)
GE   105.79 (+1.07%)
DIS   90.77 (+2.46%)
AMC   4.56 (+0.00%)
PFE   38.35 (+0.87%)
PYPL   63.96 (+1.44%)
NFLX   400.47 (-0.66%)
QQQ   354.65 (+0.75%)
AAPL   180.95 (+0.48%)
MSFT   335.40 (+0.85%)
META   272.61 (+0.00%)
GOOGL   124.67 (+0.77%)
AMZN   124.25 (+1.21%)
TSLA   213.97 (+3.11%)
NVDA   393.27 (-1.11%)
NIO   7.56 (+0.27%)
BABA   84.26 (+1.52%)
AMD   117.86 (-1.35%)
T   15.21 (-3.86%)
F   12.38 (+2.23%)
MU   69.17 (+0.12%)
CGC   0.83 (-1.20%)
GE   105.79 (+1.07%)
DIS   90.77 (+2.46%)
AMC   4.56 (+0.00%)
PFE   38.35 (+0.87%)
PYPL   63.96 (+1.44%)
NFLX   400.47 (-0.66%)
NASDAQ:RVPH

Reviva Pharmaceuticals (RVPH) Stock Forecast, Price & News

$6.78
+0.33 (+5.12%)
(As of 06/2/2023 ET)
Compare
Today's Range
$6.31
$6.92
50-Day Range
$3.93
$8.55
52-Week Range
$0.53
$9.25
Volume
180,873 shs
Average Volume
148,407 shs
Market Capitalization
$138.65 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$18.00

Reviva Pharmaceuticals MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
165.5% Upside
$18.00 Price Target
Short Interest
Bearish
7.97% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($1.01) to ($0.84) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.49 out of 5 stars

Medical Sector

834th out of 983 stocks

Pharmaceutical Preparations Industry

418th out of 486 stocks


RVPH stock logo

About Reviva Pharmaceuticals (NASDAQ:RVPH) Stock

Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for the central nervous system, respiratory, and metabolic diseases. It uses chemical genomics driven technology platform and proprietary chemistry to develop new medicines. It focuses on the RP5063 (Brilaroxazine) and RP1208 pipelines. The company was founded by Laxminarayan Bhat on December 11, 2020 and is headquartered in Cupertino, CA.

Receive RVPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Reviva Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

RVPH Stock News Headlines

Laser breakthrough could send stock soaring 2,467%
Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...
RVPH: Psoriasis IND Expected
"Unknown laser company making HUGE profit from Russia-Ukraine War"
On February 24th, Russia invaded Ukraine. This caused major stock losses and soaring gas prices. But it also created a HUGE opportunity for savvy investors. There's an unknown laser company that's been profiting greatly from this war... ...and from another major conflict happening 3,000 miles away. Learn more here >>>
Reviva Pharmaceuticals (NASDAQ:RVPH) PT Raised to $18.00
RVPH: RECOVER Parallel Studies Complete
RVPH: Brilaroxazine Enthusiasm Abounds
See More Headlines

RVPH Price History

RVPH Company Calendar

Last Earnings
11/15/2021
Today
6/02/2023
Next Earnings (Estimated)
8/21/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:RVPH
Fax
N/A
Employees
5
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$18.00
High Stock Price Forecast
$20.00
Low Stock Price Forecast
$16.00
Forecasted Upside/Downside
+179.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Net Income
$-24,340,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$0.28 per share

Miscellaneous

Free Float
13,895,000
Market Cap
$131.90 million
Optionable
Not Optionable
Beta
0.13

Key Executives

  • Laxminarayan Bhat
    President, Chief Executive Officer & Director
  • Narayan Prabhu
    Chief Financial Officer













RVPH Stock - Frequently Asked Questions

Should I buy or sell Reviva Pharmaceuticals stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Reviva Pharmaceuticals in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" RVPH shares.
View RVPH analyst ratings
or view top-rated stocks.

What is Reviva Pharmaceuticals' stock price forecast for 2023?

3 equities research analysts have issued 12-month price targets for Reviva Pharmaceuticals' shares. Their RVPH share price forecasts range from $16.00 to $20.00. On average, they anticipate the company's stock price to reach $18.00 in the next year. This suggests a possible upside of 179.1% from the stock's current price.
View analysts price targets for RVPH
or view top-rated stocks among Wall Street analysts.

How have RVPH shares performed in 2023?

Reviva Pharmaceuticals' stock was trading at $4.25 at the beginning of the year. Since then, RVPH shares have increased by 51.8% and is now trading at $6.45.
View the best growth stocks for 2023 here
.

Are investors shorting Reviva Pharmaceuticals?

Reviva Pharmaceuticals saw a increase in short interest in May. As of May 15th, there was short interest totaling 1,630,000 shares, an increase of 20.7% from the April 30th total of 1,350,000 shares. Based on an average trading volume of 150,600 shares, the short-interest ratio is currently 10.8 days.
View Reviva Pharmaceuticals' Short Interest
.

When is Reviva Pharmaceuticals' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, August 21st 2023.
View our RVPH earnings forecast
.

How were Reviva Pharmaceuticals' earnings last quarter?

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) announced its earnings results on Monday, November, 15th. The company reported ($0.12) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.23) by $0.11.

What is Reviva Pharmaceuticals' stock symbol?

Reviva Pharmaceuticals trades on the NASDAQ under the ticker symbol "RVPH."

Who are Reviva Pharmaceuticals' major shareholders?

Reviva Pharmaceuticals' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Susquehanna International Group LLP (0.00%), Colony Group LLC (0.45%), Two Sigma Investments LP (0.08%), Belvedere Trading LLC (0.00%), Group One Trading L.P. (0.00%) and Sabby Management LLC (0.00%). Insiders that own company stock include Prabhu Narayan, Purav Patel and Vedanta Partners, Llc.
View institutional ownership trends
.

How do I buy shares of Reviva Pharmaceuticals?

Shares of RVPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Reviva Pharmaceuticals' stock price today?

One share of RVPH stock can currently be purchased for approximately $6.45.

How much money does Reviva Pharmaceuticals make?

Reviva Pharmaceuticals (NASDAQ:RVPH) has a market capitalization of $131.90 million. The company earns $-24,340,000.00 in net income (profit) each year or ($1.15) on an earnings per share basis.

How can I contact Reviva Pharmaceuticals?

Reviva Pharmaceuticals' mailing address is 19925 STEVENS CREEK BLVD. SUITE 100, CUPERTINO CA, 95014. The official website for the company is www.revivapharma.com. The company can be reached via phone at (408) 501-8881 or via email at ir.revivapharma.com.

This page (NASDAQ:RVPH) was last updated on 6/2/2023 by MarketBeat.com Staff

My Account -